Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma
Innovative therapeutic strategies have emerged over the past decade to improve outcomes for most lymphoma patients. Nevertheless, the aggressive presentation seen in high-risk mantle cell lymphoma (MCL) patients remains an unmet medical need. The highly proliferative cells that characterize these t...
| Published in: | Haematologica |
|---|---|
| Main Authors: | Romane Durand, Céline Bellanger, Charlotte Kervoëlen, Benoit Tessoulin, Christelle Dousset, Emmanuelle Menoret, Hélène Asnagli, Andrew Parker, Philip Beer, Catherine Pellat-Deceunynck, David Chiron |
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2024-02-01
|
| Online Access: | https://haematologica.org/article/view/11464 |
Similar Items
Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53‐deficient myeloma cells
by: Romane Durand, et al.
Published: (2024-10-01)
by: Romane Durand, et al.
Published: (2024-10-01)
Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells
by: Benoit Tessoulin, et al.
Published: (2019-03-01)
by: Benoit Tessoulin, et al.
Published: (2019-03-01)
Differential roles of CTP synthetases CTPS1 and CTPS2 in cell proliferation
by: Norbert Minet, et al.
Published: (2023-09-01)
by: Norbert Minet, et al.
Published: (2023-09-01)
P1308: SELECTIVE SMALL MOLECULE INHIBITION OF CTP SYNTHASE 1 (CTPS1) SUPPRESSES T CELL PROLIFERATION AND CYTOKINE RELEASE, HIGHLIGHTING A NOVEL THERAPEUTIC TARGET FOR GRAFT-VERSUS-HOST DISEASE
by: P. Beer, et al.
Published: (2022-06-01)
by: P. Beer, et al.
Published: (2022-06-01)
P1214: CTPS1 ACTS AS A PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET IN MANTLE CELL LYMPHOMA
by: Yi-Min Ren, et al.
Published: (2023-08-01)
by: Yi-Min Ren, et al.
Published: (2023-08-01)
Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion
by: Diana Malarikova, et al.
Published: (2024-03-01)
by: Diana Malarikova, et al.
Published: (2024-03-01)
The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibition
by: Salomé Decombis, et al.
Published: (2022-03-01)
by: Salomé Decombis, et al.
Published: (2022-03-01)
Filamentation of hCTPS1 with CTP
by: Chen-Jun Guo, et al.
Published: (2025-07-01)
by: Chen-Jun Guo, et al.
Published: (2025-07-01)
Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways
by: Benoît Tessoulin, et al.
Published: (2018-12-01)
by: Benoît Tessoulin, et al.
Published: (2018-12-01)
P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION
by: C. Pfeiffer, et al.
Published: (2022-06-01)
by: C. Pfeiffer, et al.
Published: (2022-06-01)
Fat body-specific reduction of CTPS alleviates HFD-induced obesity
by: Jingnan Liu, et al.
Published: (2023-09-01)
by: Jingnan Liu, et al.
Published: (2023-09-01)
BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival
by: Ophélie Champion, et al.
Published: (2023-07-01)
by: Ophélie Champion, et al.
Published: (2023-07-01)
The origin of the plasma cell heterogeneity
by: Catherine ePellat-Deceunynck, et al.
Published: (2015-01-01)
by: Catherine ePellat-Deceunynck, et al.
Published: (2015-01-01)
De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer
by: Huan Zhang, et al.
Published: (2025-07-01)
by: Huan Zhang, et al.
Published: (2025-07-01)
The Effectiveness of The Handwashing Program with Soap (CTPS) In Preventing E. Coli Contamination on Elementary School Student, West Martapura South Kalimantan
by: Fauzan Mutttaqien, et al.
Published: (2024-03-01)
by: Fauzan Mutttaqien, et al.
Published: (2024-03-01)
Bcl-xL blockade targets neutrophils and synergizes with chemotherapy in lung squamous cell carcinoma
by: Abdullah Mayet, et al.
Published: (2026-03-01)
by: Abdullah Mayet, et al.
Published: (2026-03-01)
TLR9 ligand induces the generation of CD20+ plasmablasts and plasma cells from CD27+ memory B-cells
by: Alexandrine eGeffroy-Luseau, et al.
Published: (2011-12-01)
by: Alexandrine eGeffroy-Luseau, et al.
Published: (2011-12-01)
Aggressive, early resistant and relapsed mantle cell lymphoma distinct extrinsic microenvironment highlighted by transcriptome analysis
by: Yannick Le Bris, et al.
Published: (2022-11-01)
by: Yannick Le Bris, et al.
Published: (2022-11-01)
Oridonin synergizes with Nutlin-3 in osteosarcoma cells by modulating the levels of multiple Bcl-2 family proteins
by: Xiao-Hui Wang, et al.
Published: (2017-05-01)
by: Xiao-Hui Wang, et al.
Published: (2017-05-01)
Synchronous Occurrence of Splenic Pleomorphic Mantle Cell Lymphoma and Esophageal Adenocarcinoma with Overexpression of BCL1 Protein
by: Dominik Dabrowski, et al.
Published: (2020-01-01)
by: Dominik Dabrowski, et al.
Published: (2020-01-01)
Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma
by: Jing Zhang, et al.
Published: (2022-04-01)
by: Jing Zhang, et al.
Published: (2022-04-01)
Expression of caspase-3, p53 and Bcl-2 in generalized aggressive periodontitis
by: Özdemir B Handan, et al.
Published: (2006-06-01)
by: Özdemir B Handan, et al.
Published: (2006-06-01)
CTPS1 modulates mitophagy to propel diffuse large B-cell lymphoma via reshaping CEPT1-mediated phospholipid metabolismKey points
by: Chunyu Shang, et al.
Published: (2026-05-01)
by: Chunyu Shang, et al.
Published: (2026-05-01)
Dinaciclib synergizes with BH3 mimetics targeting BCL‐2 and BCL‐XL in multiple myeloma cell lines partially dependent on MCL‐1 and in plasma cells from patients
by: Manuel Beltrán‐Visiedo, et al.
Published: (2023-12-01)
by: Manuel Beltrán‐Visiedo, et al.
Published: (2023-12-01)
PB2168: BRUSATOL INDUCES APOPTOSIS IN AGGRESSIVE LYMPHOMA CELLS IN VITRO AND SYNERGIZES WITH VENETOCLAX
by: M. Szmyra, et al.
Published: (2022-06-01)
by: M. Szmyra, et al.
Published: (2022-06-01)
Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma
by: Imani Bijou, et al.
Published: (2024-01-01)
by: Imani Bijou, et al.
Published: (2024-01-01)
Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma.
by: Imani Bijou, et al.
Published: (2024-01-01)
by: Imani Bijou, et al.
Published: (2024-01-01)
Targeting HASPIN kinase disrupts SR protein–mediated RNA splicing and synergizes with BCL-2 inhibitor venetoclax in AML
by: Mengdan Liu, et al.
Published: (2025-08-01)
by: Mengdan Liu, et al.
Published: (2025-08-01)
BCL-2 mutant B7H6-CAR-T cells synergized with venetoclax for treating small cell lung cancer
by: Chen Cheng, et al.
Published: (2025-05-01)
by: Chen Cheng, et al.
Published: (2025-05-01)
Inhibition of LINK-A lncRNA overcomes ibrutinib resistance in mantle cell lymphoma by regulating Akt/Bcl2 pathway
by: Ye Zhang, et al.
Published: (2021-12-01)
by: Ye Zhang, et al.
Published: (2021-12-01)
Pemberdayaan dan Peningkatan Perilaku Cuci Tangan Pakai Sabun (CTPS) Dalam Pencegahan Penyebaran Covid-19 di Kelurahan Dorpedu Kota Ternate Provinsi Maluku Utara
by: Purnama Sidebang
Published: (2021-11-01)
by: Purnama Sidebang
Published: (2021-11-01)
Pengaruh Media Audiovisual terhadap Tingkat Pengetahuan dan Sikap Cuci Tangan Pakai Sabun (CTPS) yang Baik dan Benar di SD Yaspenhan Medan Marelan
by: Arifin Shaleh Lubis Arifin, et al.
Published: (2024-09-01)
by: Arifin Shaleh Lubis Arifin, et al.
Published: (2024-09-01)
SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma
by: Anna De Bolòs, et al.
Published: (2024-04-01)
by: Anna De Bolòs, et al.
Published: (2024-04-01)
Coronae on Venus: formation by lithospheric drag from convective cells in the mantle
by: Héctor J. Durand-Manterola
Published: (1996-01-01)
by: Héctor J. Durand-Manterola
Published: (1996-01-01)
NL101 synergizes with the BCL-2 inhibitor venetoclax through PI3K-dependent suppression of c-Myc in acute myeloid leukaemia
by: Ying Lu, et al.
Published: (2024-09-01)
by: Ying Lu, et al.
Published: (2024-09-01)
The MYRACLE protocol study: a multicentric observational prospective cohort study of patients with multiple myeloma
by: Lina Benaniba, et al.
Published: (2019-08-01)
by: Lina Benaniba, et al.
Published: (2019-08-01)
Penyuluhan perilaku hidup bersih dan sehat (PHBS) melalui cuci tangan pakai sabun (CTPS) kepada siswa SDN Panunggangan 4 sebagai upaya menanamkan nilai bela negara
by: Audrey Gondokusumo Widjaja, et al.
Published: (2026-05-01)
by: Audrey Gondokusumo Widjaja, et al.
Published: (2026-05-01)
Synergism and synergic effects in polymer`s processing technology
by: Yu. A. Naumova
Published: (2013-06-01)
by: Yu. A. Naumova
Published: (2013-06-01)
P1279: INHIBITION OF PROTEIN KINASE CK2 AND BCL-2: A NOVEL THERAPEUTIC STRATEGY TO ANTAGONIZE MANTLE CELL LYMPHOMA CELL GROWTH
by: S. Manni, et al.
Published: (2022-06-01)
by: S. Manni, et al.
Published: (2022-06-01)
Author Correction: SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma
by: Anna De Bolòs, et al.
Published: (2024-06-01)
by: Anna De Bolòs, et al.
Published: (2024-06-01)
Similar Items
-
Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53‐deficient myeloma cells
by: Romane Durand, et al.
Published: (2024-10-01) -
Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells
by: Benoit Tessoulin, et al.
Published: (2019-03-01) -
Differential roles of CTP synthetases CTPS1 and CTPS2 in cell proliferation
by: Norbert Minet, et al.
Published: (2023-09-01) -
P1308: SELECTIVE SMALL MOLECULE INHIBITION OF CTP SYNTHASE 1 (CTPS1) SUPPRESSES T CELL PROLIFERATION AND CYTOKINE RELEASE, HIGHLIGHTING A NOVEL THERAPEUTIC TARGET FOR GRAFT-VERSUS-HOST DISEASE
by: P. Beer, et al.
Published: (2022-06-01) -
P1214: CTPS1 ACTS AS A PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET IN MANTLE CELL LYMPHOMA
by: Yi-Min Ren, et al.
Published: (2023-08-01)
